Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA). While Myovant Sciences GmbH is Sumitomo Pharma Switzerland (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in psychiatry and neurology, oncology, urology, women’s health, rare disease, and cell and gene therapies. Follow us at Sumitomo Pharma America, Inc.
Myovant Sciences
Biotechnology Research
Brisbane, CA 22,900 followers
Redefining Care. For Women. For Men. For You.
About us
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive. Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
- Website
-
http://www.myovant.com
External link for Myovant Sciences
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Brisbane, CA
- Type
- Public Company
- Founded
- 2016
Locations
-
Primary
2000 Sierra Point Parkway
9th Floor
Brisbane, CA 94005, US
-
Viaduktstrasse 8
Basel, 4051, CH
Employees at Myovant Sciences
-
Simon Holt
Access/Value Evidence/HEOR/RWE in LifeSciences
-
Sang Lee
Myovant Sciences, Director of Commercial Operations
-
Elke Hunsche
Market Access / Health Economics / Outcomes Research / Pricing / Leadership / Results-driven and Science-based
-
Julia Itskevitch
Lead Statistical Programmer Consultant at Acerta Pharma